Published Date: 16 Feb 2023
Many physicians have encountered one or more serious or potentially dangerous patients over the years, and according to Medscape research, patient trust has declined.
Read Full NewsTechnique deemed safe and feasible for selected patients and better than other minimally invasive approaches
Cardiomyopathy risks interrupting cancer treatment, worsening prognosis
— News, features, and commentary about cancer-related issues
1.
AI tool automates liver tumor detection and monitoring
2.
AI-Driven Biomarker Predicts Prostate Cancer Outcomes
3.
Year in Review: Multiple Myeloma
4.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
5.
Breast Cancer Incidence Rises in Asian American Women
1.
Red Cell Deformability as a Target in Critical Illness
2.
Emerging Models in Oncology for Specialists
3.
Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine
4.
Cloud-Based Hematology Decision Support Platforms: Transforming Clinical Practice Through Digital Innovation
5.
Engineered Niches for Blood-Cell Regeneration: Current Concepts and Clinical Implications
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
1.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
2.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
3.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
5.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation